HROW: Harrow Inc

HROW News

• 11:17 Harrow appoints Andrew R. Boll as president and names Randall E. Pollard chief accounting officer
• 22:38 Harrow Baby Bonds Yield Review (NASDAQ:HROW)
• 16:20 Surging Earnings Estimates Signal Upside for Harrow (HROW) Stock
• 14:00 Best Momentum Stock to Buy for August 15th
• 13:55 Wall Street Analysts Think Harrow (HROW) Could Surge 53.24%: Read This Before Placing a Bet
• 03:09 Harrow Stock's Ambitious Guidance Puts It In The Proving Ground (NASDAQ:HROW)
• 07:00 Harrow Stock Eyes Relative Strength Rating Upgrade
• 21:39 Harrow: Exciting Times In Store (NASDAQ:HROW)
• 11:44 H.C. Wainwright raises Harrow Health stock price target on VEVYE growth
• 18:48 Harrow, Inc. 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:HROW)
• 18:47 Harrow, Inc. (HROW) Q2 2025 Earnings Call Transcript
• 21:34 Harrow Health Q2 2025 slides: Mixed results amid strategic portfolio expansion
• 20:13 Harrow Health earnings beat by $0.23, revenue fell short of estimates
• 18:00 Barrick Gold, Roivant Sciences, Owens & Minor to report earnings Monday
• 14:00 Harrow (HROW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
• 17:51 Undercovered Dozen: Christian Dior, Coca-Cola, Trinity Capital, Amgen And More
• 13:14 Harrow Health stock outlook strong as Cantor reiterates Overweight rating
• 11:40 H.C. Wainwright reiterates Buy rating on Harrow Health stock at $60 target
• 11:10 Harrow acquires exclusive US rights to Samsung Bioepis eye drugs
• 14:01 Harrow (HROW) Stock Jumps 11.4%: Will It Continue to Soar?
• 21:47 Harrow's Internal $100 Price Target Is Ambitious, But Bloomberg Data Backs It Up (HROW)
• 16:01 This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Harrow (NASDAQ:HROW), Janux Therapeutics (NASDAQ:JANX)
• 11:39 Cantor Fitzgerald initiates Harrow Health stock with Overweight rating
• 18:52 Harrow: Immense Upside Potential (NASDAQ:HROW)